首页> 美国卫生研究院文献>Journal of Oncology Practice >Documentation of Oral Versus Intravenous Chemotherapy Plans in Patients With Metastatic Non–Small-Cell Lung Cancer

【2h】

Documentation of Oral Versus Intravenous Chemotherapy Plans in Patients With Metastatic Non–Small-Cell Lung Cancer

机译：转移性非小细胞肺癌患者的口服对静脉化疗方案的文献记录

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

获取外文期刊封面目录资料

页面导航

摘要
著录项
引文网络
相似文献
相关主题

摘要

Purpose:Using the ASCO Quality Oncology Practice Initiative (QOPI) guidelines for assessing quality cancer care, we examined differences in clinician documentation of patient consent and treatment plans for oral versus intravenous chemotherapy among patients with metastatic non–small-cell lung cancer (NSCLC).

机译：目的：使用ASCO质量肿瘤实践计划（QOPI）指南评估高质量的癌症治疗，我们研究了转移性非小细胞肺癌（NSCLC）患者在患者同意书以及口服和静脉化疗方案之间的临床医生差异。

著录项

期刊名称 Journal of Oncology Practice
作者
Joseph A. Greer; Inga T. Lennes; Emily R. Gallagher; Jennifer S. Temel; William F. Pirl;
展开▼
作者单位

展开▼
年(卷),期 2014(10),2
年度 2014
页码 e103–e106
总页数 4
原文格式 PDF
正文语种
中图分类肿瘤学;
关键词

相似文献

外文文献
中文文献
专利

1. Documentation of Oral Versus Intravenous Chemotherapy Plans in Patients With Metastatic Non–Small-Cell Lung Cancer [J] . Joseph A. Greer, Inga T. Lennes, Emily R. Gallagher, Journal of Oncology Practice . 2014,第2期

机译：转移性非小细胞肺癌患者的口服对静脉化疗方案的文件
2. A randomised, multicentre open-label phase II study to evaluate the efficacy, tolerability and pharmacokinetics of oral vinorelbine plus cisplatin versus intravenous vinorelbine plus cisplatin in Chinese patients with chemotherapy-naive unresectable or metastatic non-small cell lung cancer [J] . Yunpeng Yang, Jianhua Chang, Cheng Huang, Journal of Thoracic Disease . 2019,第8期

机译：随机的多期式开放标签期II研究，评价口服血列碱加顺铂与静脉内血红素素加顺铂的疗效，耐受性和药代动力学在中国化疗 - 幼稚不可切除或转移性非小细胞肺癌中
3. 2LB Phase III, randomized, open-label, parallel-group study of oral gefitinib (IRESSA) versus intravenous docetaxel in patients with locally advanced or metastatic non-small-cell lung cancer who have previously received platinum- based chemotherapy (INTEREST) [J] . J.Y.Douillard, E.S.Kim, V.Hirsh, European Journal of Cancer Supplements . 2007,第6期

机译：2LB口服吉非替尼（IRESSA）与静脉多西紫杉醇在先前接受过铂类化疗（INTEREST）的局部晚期或转移性非小细胞肺癌患者中进行的口服吉非替尼（IRESSA）与静脉多西紫杉醇随机对照试验
4. Pemetrexed versus docetaxel single agent chemotherapy in chemotherapy-naive elderly patients with advanced non-small cell lung cancer [C] . Hua Xin, Zhenguo Han, Haibo Huang 2011 International Conference on Human Health and Biomedical Engineering . 2011

机译：培美曲塞与多西他赛单药化疗在未接受化疗的老年晚期非小细胞肺癌患者中的作用
5. Patient Derived Xenograft Models of Small-cell Lung Cancer Provide Molecular Insights into Mechanisms of Chemotherapy Cross-resistance [D] . Myers, David T. 2018

机译：小细胞肺癌的患者衍生异种移植模型为化学疗法交叉耐药机制提供分子见解
6. A randomised multicentre open-label phase II study to evaluate the efficacy tolerability and pharmacokinetics of oral vinorelbine plus cisplatin versus intravenous vinorelbine plus cisplatin in Chinese patients with chemotherapy-naive unresectable or metastatic non-small cell lung cancer [O] . Yunpeng Yang, Jianhua Chang, Cheng Huang, 2019

机译：一项随机多中心开放标签的II期临床研究评估口服长春瑞滨联合顺铂与静脉内长春瑞滨联合顺铂在中国初治为未经化疗或无法切除的转移性非小细胞肺癌患者中的疗效耐受性和药代动力学
7. A randomised, multicentre open-label phase II study to evaluate the efficacy, tolerability and pharmacokinetics of oral vinorelbine plus cisplatin versus intravenous vinorelbine plus cisplatin in Chinese patients with chemotherapy-naive unresectable or metastatic non-small cell lung cancer [O] . Yunpeng Yang, Jianhua Chang, Cheng Huang, 2019

机译：随机的多期式开放标签期II研究，评价口服血列碱加顺铂与静脉内血红素素加顺铂的疗效，耐受性和药代动力学在中国化疗 - 幼稚不可切除或转移性非小细胞肺癌中

Documentation of Oral Versus Intravenous Chemotherapy Plans in Patients With Metastatic Non–Small-Cell Lung Cancer

摘要

著录项

引文网络

相似文献

相关主题

期刊订阅